In France, they recalled the only condition for the use of the Russian Sputnik V vaccine in the EU. It must be approved by the European Medicines Agency (EMA), French Foreign Minister Jean-Yves Le Drian said on the air of Europe 1 radio station.
“Vaccines have no nationality. It is important that the drug is effective, ”he added. According to Le Drian, EMA approval is the only obstacle to drug distribution.
French President Emmanuel Macron also said earlier that the vaccine cannot be distributed on the territory of the republic until the Russian manufacturer submits an application for registration of the drug to European authorities.
On February 2, in the medical journal Lancet, data appeared that the results of the third phase of clinical trials of the Russian Sputnik V vaccine demonstrated 91.6 percent effectiveness against coronavirus. 19,866 people took part in testing the vaccine. German Chancellor Angela Merkel praised this data.
Sputnik V became the world's first registered vaccine based on the human adenovirus. Currently, the development of Russian scientists is among the ten best vaccine candidates in the list of the World Health Organization (WHO).
